Viracta Therapeutics

Viracta Therapeutics

Viracta Therapeutics

Viracta is advancing medicines based on its viral gene activation therapy approach to benefit patients with viral-associated cancers & other serious diseases.
Suggest edits
Raised
$18.4M
Follow us
Also headquartered in San Diego
Companies in the same industry
Alexa global traffic share
Twitter followers
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1

Add info
Add round
04 Apr 2017
$18,400,000
Venture capital (Series B)
Wicklow Capital, Latterell Venture Partners, Forward Ventures, +1

Viracta nabs $18.4M, Soon-Shiong as vice chair in Series B

FierceBiotech